Chong Kun Dang Launches "EsoDuo Mini" for Gastroesophageal Reflux Disease Treatment
Reduced Tablet Size for "EsoDuo S"
Improved Dosing Convenience for Patients Requiring Long-Term Medication
On June 2, Chong Kun Dang announced the launch of "EsoDuo Mini," a reduced-size formulation of its gastroesophageal reflux disease (GERD) treatment "EsoDuo S."
EsoDuo Mini is designed to alleviate the physical discomfort that GERD patients—who frequently need long-term medication due to recurrent symptoms—often experience when swallowing pills. By significantly reducing the tablet size, the product aims to improve dosing convenience.
This product has demonstrated pharmaceutical equivalence to EsoDuo S 20/700 mg. In addition, the amounts of esomeprazole, the main ingredient in EsoDuo S, and sodium bicarbonate have both been halved to enhance medication adherence.
A representative from Chong Kun Dang stated, "EsoDuo Mini meets the key needs in the GERD treatment market—'rapid symptom relief' and 'improved dosing convenience.' By strengthening the EsoDuo brand lineup, we aim to maximize synergy with existing products and further expand our presence in the gastrointestinal therapeutics market."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Chong Kun Dang's "EsoDuo" is a combination drug consisting of esomeprazole, a proton pump inhibitor (PPI), and sodium bicarbonate, an antacid. It maintains esomeprazole's acid-suppressing effect while delivering a faster onset of action compared to monotherapy. The mechanism involves sodium bicarbonate rapidly increasing the gastric pH, which prevents esomeprazole from breaking down in the acidic environment. As a result, the drug reaches its peak blood concentration within 30 minutes of administration, providing rapid relief of GERD symptoms.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.